The Medical University of Vienna is a public university located in Vienna, Austria. It is the direct successor to the faculty of medicine at the University of Vienna, founded in 1365 by Rudolf IV, Duke of Austria.

During the past decade, Medical University Vienna, Institute of Specific Prophylaxis and Tropical Medicine conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medical University Vienna, Institute of Specific Prophylaxis and Tropical Medicine" #1 collaborator was "Valneva Austria GmbH" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Medical University Vienna, Institute of Specific Prophylaxis and Tropical Medicine" are "Japanese Encephalitis Vaccine" (1 trials), "Tick Borne Encephalitis" (1 trials), "Tick-borne Encephalitis" (1 trials), "Vaccine Responsiveness During Allergy De-sensitization Treatment" (1 trials) and "Vaccine Responsiveness in Allergy" (1 trials). Many other conditions were trialed in "Medical University Vienna, Institute of Specific Prophylaxis and Tropical Medicine" in a lesser frequency.

Most popular intervention types in "Medical University Vienna, Institute of Specific Prophylaxis and Tropical Medicine" are "Biological" (4 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "FSME-IMMUN Vaccine" (1 trials), "IXIARO®- Japanese Encephalitis vaccine" (1 trials), "One MV-ZIKA-RSP vaccination (high dose) and one placebo" (1 trials), "TBE booster vaccination" (1 trials) and "TBE vaccination and influenza vaccination" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medical University Vienna, Institute of Specific Prophylaxis and Tropical Medicine" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Medical University Vienna, Institute of Specific Prophylaxis and Tropical Medicine". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Medical University Vienna, Institute of Specific Prophylaxis and Tropical Medicine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Medical University Vienna, Institute of Specific Prophylaxis and Tropical Medicine, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".